Stay updated with breaking news from Mc Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PARIS, FRANCE / ACCESSWIRE / May 15, 2023 / Abivax (Euronext Paris: FR0012333284 - ABVX), a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the immune system
Combination of DNA biomarkers with microbiome biomarkers has potential to enhance technical profile of novel pancreatic cancer screening test Joint research project to discover disease specific... | May 10, 2023
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous Mainz Biomed Partners with Microba Life Sciences for the Development of PancAl...
Planegg/Martinsried, May 8, 2023. Medigene AG , an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will present at the following... | May 8, 2023
EQS-News: Heidelberg Pharma AG / Key word(s): Personnel Heidelberg Pharma appoints Chief Financial Officer 05.05.2023 / 12:25 ...